Identification, induction and localization of cytochrome P450s of the 3A-subfamily in mouse brain
- PMID: 14715464
- DOI: 10.1007/BF03033195
Identification, induction and localization of cytochrome P450s of the 3A-subfamily in mouse brain
Abstract
Several cytochrome P450 subfamilies are inducible by specific exogenous compounds like the antiepileptic drug phenytoin. Some of these P450 enzymes are involved in the metabolism of gonadal hormones also contributing to neuronal differentiation. CYP3A enzymes have the capacity to catalyze the hydroxylation of testosterone and a wide variety of therapeutic agents, but little is known about the expression and potential function of this subfamily in mouse brain. Here, we report the identification of mouse CYP3A isoforms, their induction and localization in mouse brain. Western blot analysis with anti-CYP3A1 antibodies revealed the phenytoin-inducible expression of CYP3A in brain microsomes, and also a constitutive expression of members of this subfamily in brain mitochondria. Using RT-PCR with a consensus primer pair for known mouse liver CYP3A-isoforms we could demonstrate the expression of CYP3A11 and 3A13 mRNA in mouse brain. Finally, using double immunofluorescence labeling we analyzed the histoanatomical distribution of CYP3A throughout the brain with confocal laser scanning microscopy. We found strong immunoreactivity in neurons of hippocampus and hypothalamic areas which are sensitive to steroid hormones. CYP3A immunoreactivity was apparent also in neurons of the cerebellum, the thalamus and the olfactory bulb. Non-neuronal expression of CYP3A could be found in some astrocyte populations and in vascular as well as ventricular border lines. The presence of CYP3A predominantly in neurons but also in cells contributing to the blood-brain and blood-liquor barrier suggests important roles of this subfamily in mediation of steroid hormone action in mouse brain as well as in preventing the brain from potentially cytotoxic compounds.
Similar articles
-
Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms.J Neuroendocrinol. 1999 Aug;11(8):597-604. doi: 10.1046/j.1365-2826.1999.00371.x. J Neuroendocrinol. 1999. PMID: 10447797
-
Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain.Neuroscience. 2003;117(3):521-9. doi: 10.1016/s0306-4522(02)00955-7. Neuroscience. 2003. PMID: 12617959
-
7-Benzyloxyresorufin-O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse liver.Anal Biochem. 2010 Mar 1;398(1):104-11. doi: 10.1016/j.ab.2009.11.004. Epub 2009 Nov 10. Anal Biochem. 2010. PMID: 19903449
-
Expression and function of cytochrome p450 in brain drug metabolism.Curr Drug Metab. 2007 May;8(4):297-306. doi: 10.2174/138920007780655478. Curr Drug Metab. 2007. PMID: 17504219 Review.
-
Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.Anticancer Drug Des. 1999 Dec;14(6):473-86. Anticancer Drug Des. 1999. PMID: 10834269 Review.
Cited by
-
Role of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract.Antimicrob Agents Chemother. 2014;58(3):1713-22. doi: 10.1128/AAC.02031-13. Epub 2013 Dec 30. Antimicrob Agents Chemother. 2014. PMID: 24379203 Free PMC article.
-
Cytochrome P4503A: evidence for mRNA expression and catalytic activity in rat brain.Mol Cell Biochem. 2006 Jul;287(1-2):91-9. doi: 10.1007/s11010-005-9080-8. Epub 2006 May 4. Mol Cell Biochem. 2006. PMID: 16673044